Abagovomab has been developed by the pharmaceutical company Menarini.
He became involved in a project financed mostly by Menarini Pharmaceuticals, aimed at the rationalization of the biochemical activity of a number of phospholipase A2 (PLA2) enzymes from different sources and, ultimately, at the design of novel inhibitors of human synovial fluid PLA2 tagged as anti-inflammatory agents.
The Fiat 306 was delivered as a chassis which was later added a car body by different companies, including CANSA, Carrozzeria Orlandi, Menarini and others.
Menarini |